Makary was the rare FDA chief who actually stood up to Big Pharma and Big Food instead of caving to their lobbying. His push to remove outdated safety warnings on menopause treatments and target ultra-processed foods showed real commitment to public health over corporate profits. Forcing him out is a win for special interests, not for Americans.
Makary slow-walked a critical safety review of mifepristone for political reasons while publicly claiming progress — a betrayal of the pro-life voters who put this administration in power. With abortion rates rising post-Dobbs and mail-order abortion drugs still flowing freely, the FDA under Makary made things worse, not better. His resignation is a necessary reset.
© 2026 Improve the News Foundation.
All rights reserved.
Version 7.4.1